Company & Sponsor Intelligence
Copenhagen University Hospital, Rigshospitalet
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting1
Completed4
Countries1
Therapeutic footprint
alzheimersepilepsymultiple_sclerosisneuromuscularother_neurology
Indexed studies
NCT03533530Clinical Utility of ESI in Presurgical Evaluation of Patients With Epilepsy
epilepsy · DenmarkNA
epilepsy · DenmarkNA
NCT02959658Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis
multiple_sclerosis · DenmarkPHASE2
multiple_sclerosis · DenmarkPHASE2
NCT03290040Identification of Predictors for Early Cognitive Decline in Men
alzheimers · DenmarkCOMPLETED
alzheimers · DenmarkCOMPLETED
NCT06337864Effect of Large Neutral Amino Acids in Adults With Classical Phenylketonuria
other_neurology · DenmarkNA
other_neurology · DenmarkNA
NCT01350154Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients
neuromuscular · DenmarkPHASE2
neuromuscular · DenmarkPHASE2
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →